Kristin Yarema
CIK: 0001803794
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Aug 14, 2026IMA
ImageneBio, Inc.
Award(A)Direct254.8K shares- - Jul 25, 2026IMA
ImageneBio, Inc.
Exercise(M)Direct38.4K shares- - Jul 25, 2026IMA
ImageneBio, Inc.
Other(J)Direct115.1K shares- - Mar 16, 2026IMA
ImageneBio, Inc.
Award(A)Direct85.4K shares- - Jul 28, 2025IMA
ImageneBio, Inc.
Award(A)DirectRestricted Stock Units
153.5K shares- - Jul 28, 2025IMA
ImageneBio, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
460.5K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
345.2K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Tender Offer(U)Direct615.8K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
498.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 |  IMA ImageneBio, Inc. | Award(A) | 254,800 | - | $0 | Direct |
| Jul 25, 2026 | IMA ImageneBio, Inc. | Exercise(M) | 38,376 | - | $0 | Direct |
| Jul 25, 2026 | IMA ImageneBio, Inc. | Other(J) | 115,129 | - | $0 | Direct |
| Mar 16, 2026 | IMA ImageneBio, Inc. | Award(A) | 85,400 | - | $0 | Direct |
| Jul 28, 2025 | IMA ImageneBio, Inc. | Award(A) Restricted Stock Units | 153,505 | - | - | Direct |
| Jul 28, 2025 | IMA ImageneBio, Inc. | Award(A) Employee Stock Option (Right to Buy) | 460,515 | - | - | Direct |
| Jan 8, 2025 |  PSTX Poseida Therapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 345,200 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Tender Offer(U) | 615,836 | - | $0 | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 498,325 | - | - | Direct |
1-9 of 9 transactions
About Yarema Kristin
Yarema Kristin (SEC CIK 0001803794) files insider reports with the SEC as Chief Executive Officer of ImageneBio, Inc. (IMA) and President and CEO of Poseida Therapeutics, Inc. (PSTX).
Signal8 holds 6 ownership filings by Yarema Kristin (1 Form 3, 5 Form 4), filed between Jan 8, 2025 and Aug 17, 2026. Those filings report 9 transactions, from Jan 8, 2025 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Yarema Kristin's filings is in SAN DIEGO, CA.
Recent filings by Yarema Kristin
- Aug 14, 2026: Grant or award of IMA shares (Form 4, code A).
- Jul 25, 2026: Option exercise of IMA shares (Form 4, code M).
- Jul 25, 2026: Other transaction of IMA shares (Form 4, code J).
- Mar 16, 2026: Grant or award of IMA shares (Form 4, code A).
- Jul 28, 2025: Grants or awards of IMA derivative securities (2 lines, Form 4, code A).
Other insiders filing for ImageneBio, Inc. (IMA)
- Grant-Huerta Yanina, Chief Financial Officer
- Lally Robert B, Principal Accounting Officer
- Wang Jonathan Jian, Director
- Stampacchia Otello, Director
- SLATTERY JOSEPH P, Director
- Bonita David P, Director